Target intelligence / Profile preview

Cilia- and flagella-associated protein 36 (CFAP36)

Target
CFAP36
Molecular classification
Other (Structural ciliary/flagellar protein, coiled-coil domain-containing protein)
01

Overview

Cilia- and flagella-associated protein 36 (CFAP36) is a structural protein localized to the ciliary transition zone and is involved in regulating ciliary transport processes. It contains a BART-like domain and directly interacts with the small GTPase Arl3, modulating its localization and potentially facilitating presentation to GTPase-activating proteins. The protein is expressed in multiple human tissues, including the brain, testis, heart, lung, pancreas, and spleen. Loss or mutation of CFAP36 is linked to disorders such as retinitis pigmentosa and Joubert syndrome, likely due to its importance in ciliary integrity and function. CFAP36 is noted as an autoantigen in some cases of paraneoplastic neurological syndromes with anti-Yo antibodies. It is not recognized as a classical drug target such as a receptor or enzyme, but rather plays a structural and regulatory role in the ciliary apparatus.

Other names
CCDC104BARTL1Coiled-coil domain-containing protein 104UNQ163/PRO189MGC15407CFA36_HUMAN
02

Mechanism of action

No drugs targeting this molecule; primary role is structural/regulatory in ciliary function

03

Biological functions

Regulation of ciliary transportModulation of ciliary assembly and functionCiliary localization of small GTPase Arl3Possibly acts as effector for ARL3Component of ciliary transition zone
04

Disease associations

Retinitis pigmentosaJoubert syndromeParaneoplastic neurological syndromes (as autoantigen in some anti-Yo antibody associated cases)

Beyond the preview

Go deeper on Cilia- and flagella-associated protein 36 (CFAP36).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cilia- and flagella-associated protein 36 (CFAP36).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call